Solutions · Venture capital + PE

The thesis looks
stronger than
the evidence does.

Every investment thesis has a critical assumption that hasn’t been stress-tested. The market size that’s sourced from a single analyst report. The competitive moat claim that doesn’t survive scrutiny of the incumbent’s roadmap. The unit economics that only work at a scale the company hasn’t reached. Augle runs the adversarial review before capital is deployed.

VC partners stress-testing investment theses pre-IC
PE associates conducting diligence on acquisition targets
Growth equity teams evaluating market sizing assumptions
Portfolio operations teams assessing competitive positioning
Session configuration
Guardian modeFinancial integrity
DepthStandard · Deep
DocumentsMemos · models · market reports · CIMs
SVS checksMarket data recency · source attribution · forecast vs. historical distinction
OutputFinding · confidence grade · key risks verbatim · audit trail
The problem

Investment committees find what diligence missed.

IC pushback isn’t random. It targets the same structural weaknesses every time: market size claims that can’t be triangulated, moat assertions that don’t survive a look at the competitor roadmap, and unit economics that require assumptions the company hasn’t validated. The deal team that walks in knowing these objections wins the room. The one that hears them for the first time loses it.

Questions VC and PE teams run on Augle

What is the strongest argument against our TAM estimate, and how should we address it at IC?
Does the claimed competitive moat survive scrutiny of the incumbent’s announced product roadmap?
Which unit economics assumptions are most sensitive to the company not reaching projected scale?
Is the evidence for this market’s regulatory tailwind as established as the founder claims?
What would need to be true for this acquisition’s revenue synergy assumptions to hold?
TAM estimates sourced from single analyst reports

The Cartographer maps the evidence behind every market size claim — whether it’s triangulated across multiple independent sources or dependent on a single Gartner or IDC figure from 2022. The Methodologist flags when a bottom-up construction and a top-down estimate produce materially different numbers that the memo treats as equivalent.

Moat claims that don’t survive incumbent scrutiny

The Contrarian steelmans the incumbent’s position before challenging the moat thesis. A switching cost argument that depends on integrations the incumbent announced at their last developer conference, or a network effect claim in a market where the largest player has already replicated the core feature, surfaces here — not at IC.

Unit economics that only work at unvalidated scale

The Methodologist evaluates whether the construct — whether the unit economics model actually measures what the memo claims — holds at the growth stage being underwritten. CAC that’s been validated at 50 enterprise customers may not hold at 500. Gross margin that assumes a pricing tier the company hasn’t yet launched is Contested, not Probable.

The IC objection you haven’t prepared for

The Contrarian runs at maximum temperature to surface the objection a skeptical IC member or a competing bidder’s advisor will raise. Unresolved Strong objections appear verbatim in the session output — not summarised, not softened — with a specified resolution condition. These become the IC prep agenda.

How it works in practice

Three sessions.
Three investment moments.

Each scenario illustrates realistic deliberation behaviour across thesis validation, diligence review, and competitive assessment.

Use case 01 of 03 · Venture capital + PE
The Investment Thesis Review
Principal · Series B growth fund · Pre-IC memo finalisation
Standard depth · document ingestion

Is the investment thesis for this vertical SaaS company’s Series B defensible at IC, and what are the two or three objections we need to resolve before we go in?

CartographerSettled: the category exists and the company has product-market fit in its initial segment. Contested: whether the $4.2B TAM figure is achievable given the company’s actual ICP. Unknown: the timeline and cost of expanding from the current segment to the adjacent verticals that make up 60% of the TAM claim.
MethodologistConstruct validity: the TAM is sourced from a single 2023 Forrester report using a definition of the category that includes use cases the company doesn’t currently address. Bottom-up calculation from the company’s own pipeline data produces a $1.1B serviceable figure. These are treated as equivalent in the memo. They are not.
ContrarianStrong objection (Unresolved): "The moat argument depends on proprietary workflow integrations. Salesforce announced equivalent native functionality at Dreamforce in September. The integration advantage has a 12–18 month shelf life at most. IC will ask this."
Pragmatist(1) Restate the TAM using the bottom-up figure with the Forrester number as long-run ceiling — more defensible. (2) Prepare a direct response to the Salesforce roadmap question: what specific integrations remain proprietary and for how long? These are the two slides IC will focus on.
Session output
FindingProbable for near-term thesis · Contested for long-run TAM and moat durability
Key objectionSalesforce native functionality — integration moat has 12–18 month horizon
TAM gap$4.2B Forrester vs. $1.1B bottom-up — not reconciled in memo
IC prepRestate TAM + prepare moat durability slide before IC
The value

The Salesforce roadmap conflict wasn’t in the competitive analysis. The TAM discrepancy was in the memo but hadn’t been flagged. The partner who walked into IC knowing both objections controlled the room. The one who heard them for the first time didn’t.

Use case 02 of 03 · Venture capital + PE
The Acquisition Diligence Review
VP · Mid-market PE fund · Proprietary deal · Pre-LOI
Deep depth · document ingestion

Do the revenue synergy assumptions in our acquisition model for this add-on hold under scrutiny, and what’s the strongest case against our post-close integration timeline?

CartographerSettled: the customer overlap creates genuine cross-sell opportunity. Contested: whether the platform’s two separate CRM systems can be integrated within the 18-month timeline the model assumes. Unknown: customer willingness to migrate — no channel checks have been done with the target’s top 10 accounts.
MethodologistThe revenue synergy figure assumes 35% of the target’s existing customers will adopt the acquirer’s premium tier within 24 months. The comparable from the fund’s last add-on shows 12% adoption over 36 months. The assumption is 3x the empirical base rate. Confidence: Contested.
ContrarianModerate objection: "The integration timeline assumes parallel CRM migration with no customer disruption. Every PE integration of this type in the past five years has experienced 6–9 month delays. The model has no contingency for this. The synergy realisation schedule needs a sensitivity case."
Session output
FindingContested — revenue synergies 3x empirical base rate; integration timeline has no contingency
Key riskCRM integration delay + customer adoption rate materially overstated vs. comparable
Next stepAdd 6–9 month delay sensitivity case. Run channel checks with top 10 target accounts pre-LOI.
The value

The adoption rate assumption was buried in a tab of the model. The CRM integration risk was described in the CIM as “manageable.” Neither had been stress-tested against the fund’s own comparable. The sensitivity case was added before the LOI was signed, not discovered in the 100-day plan.

Use case 03 of 03 · Venture capital + PE
The Competitive Positioning Check
Associate · Early-stage fund · Seed extension diligence
Standard depth

Is the founder’s claim that they have a two-year technical lead over the nearest competitor supported by the available evidence?

CartographerSettled: the company’s inference latency benchmarks are meaningfully better than the published figures from the nearest competitor. Contested: whether inference latency is the primary purchase criterion at the company’s current ICP. Unknown: the competitor’s internal roadmap — only public statements available.
ContrarianStrong objection (Unresolved): "The ‘two-year lead’ claim is based on a benchmark the company designed and self-published. There is no independent third-party validation. The competitor has not published equivalent benchmarks — absence of evidence is not evidence of absence. This claim will not survive a technical reference check."
SynthesizerThe inference latency advantage is real based on available data. The two-year lead claim is not supported — it conflates a current benchmark advantage with a durable technical moat. These are different claims requiring different evidence. The memo should reflect this distinction.
Session output
FindingProbable for current benchmark advantage · Gap for two-year lead durability claim
Key objectionSelf-published benchmark — no independent validation; competitor roadmap unknown
Next stepCommission independent technical reference. Restate as benchmark advantage, not two-year lead.
The value

The two-year lead was the headline claim in the founder deck. It was also the weakest claim in the deck. Restating it accurately — a real and measurable benchmark advantage, not an asserted durable moat — strengthened the memo’s credibility with IC rather than exposing it to a single pointed question.

How Augle works for VC and PE

IC prep that runs the
objections before you do.

1
Submit your deal materials

Upload memos, financial models, market reports, CIMs, and management presentations. Financial integrity mode activates automatically — the Guardian validates market data recency, distinguishes historical data from forward forecasts, and flags stale or single-source market size claims.

2
The ensemble maps what’s contested

The Cartographer classifies every key assumption as Settled, Contested, or Unknown. The Methodologist assesses construct validity — whether the metrics in the model actually measure what the memo claims. TAM definitions, unit economics constructs, and synergy assumptions are evaluated against the evidence base before deliberation begins.

3
The IC objections are run

The Contrarian takes the role of a skeptical IC member or a competing bidder’s advisor — surfacing the strongest version of every challenge to the thesis. Every objection specifies a resolution condition. Unresolved Strong objections become the IC prep agenda, not the IC surprise.

4
You receive a calibrated risk register

The Synthesizer produces a finding anchored to the evidence base — not the founder narrative. Confidence grades per key assumption, unresolved objections verbatim with resolution conditions, and reopen conditions that specify what new information would change the assessment.

VC/PE session · configuration
Guardian mode
Financial integrity — market data recency, forecast vs. historical distinction, source attribution, financial advice prohibition
Document types
Investment memos · Financial models · CIMs · Market reports · Management presentations · Comparable transaction data
Contrarian focus
TAM triangulation · moat durability · unit economics at scale · integration timeline realism · competitive roadmap exposure
Output package
Confidence grade per key assumption · unresolved IC objections verbatim · reopen conditions · full audit trail
Session depth
Standard for thesis review and IC prep · Deep for major acquisitions with external expert at Phase 1/2 boundary
Why Augle for VC and PE

The IC objection surfaced
before the meeting.

Runs the skeptical IC member’s objections

The Contrarian is calibrated to surface the strongest version of every challenge to your thesis — the TAM triangulation question, the moat durability challenge, the unit economics sensitivity. Unresolved objections appear verbatim with resolution conditions. The deal team that knows these going in controls the IC conversation.

Validates market data before it enters the memo

Financial integrity mode checks market data recency, source attribution, and the distinction between historical data and forward forecasts. A $4B TAM from a 2021 report that used a category definition your company doesn’t address is flagged before it becomes the first thing IC questions. Stale data doesn’t survive SVS.

Produces a confidence-graded risk register

Every key assumption receives a confidence grade — Established, Probable, Contested, or Gap — based on the evidence base, not the memo’s framing. The difference between a Probable thesis and a Contested one is the difference between a memo that IC approves and one that generates a 30-minute objection loop on the first key assumption.

Know the IC objections
before the meeting.

Join waitlist and stress-test your next investment thesis before you go to committee.